ilikefinance

Climate Change and Central Banks: Why We Can’t Just Sit Back and Relax

Central Banks and Climate Change: Finding the Balance BoJ Kuroda’s Perspective At an event in Stockholm, BoJ Governor Haruhiko Kuroda emphasized the importance of central banks maintaining their independence from governments when it comes to addressing climate change. He highlighted the need for central banks to make autonomous decisions within their mandate, taking a long-term…

Read More

Important Class Action Reminders for CTXS, GAIA, and DAKT Investors: Don’t Miss Out on Your Opportunity to Participate!

Class Action Lawsuit Reminder New York, Jan. 06, 2023 (GLOBE NEWSWIRE) Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Law…

Read More

Compass Diversified Announces Q4 2022 Distributions for Common and Preferred Shares

Compass Diversified Declares Fourth Quarter 2022 Distributions on Common and Series A, B and C Preferred Shares Overview WESTPORT, Conn., Jan. 04, 2023 (GLOBE NEWSWIRE) — Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, announced today that its Board of Directors (the “Board”) has declared a quarterly cash…

Read More

Global Diversified Marketing Group CEO Paul Adler Shares Exciting Updates on 2022 Events and Corporate Outlook for 2023

Global Diversified Marketing Group CEO Paul Adler Updates 2022 Events and Corporate Outlook for 2023 Global Diversified Marketing Group Overview ISLAND PARK, N.Y., Jan. 03, 2023 (GLOBE NEWSWIRE) — Global Diversified Marketing Group Inc., a Delaware corporation (OTC: GDMK), operates as a diversified holdings company through several divisions. One of its divisions focuses on global…

Read More

Breaking News: Oncoc4 Begins Groundbreaking Clinical Trial for Ovarian Cancer Treatment with Keytruda

Exciting News in Cancer Treatment: OncoC4 Announces Phase 2 Combination Trial Breaking Ground in Cancer Research The Phase 2 multicenter, open-label combination trial by OncoC4, Inc. marks a significant advancement in the field of cancer treatment. This new trial builds upon the promising results of ONC-392 seen in previous clinical trials, offering hope to patients…

Read More